Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Bourke

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
BMJ Case Reports|July 19, 2022
Transient cryoglobulinaemic vasculitis following ChAdOx1 nCoV-19 vaccineSadaf Ahmer, Jack Bourke, Nima Mesbah Ardakani
The Journal of Allergy and Clinical Immunology. in Practice|January 23, 2015
Improving the Effectiveness of Penicillin Allergy De-labelingJack Bourke, Rebecca Pavlos, Ian James, et al.
The Clinical Biochemist. Reviews|April 18, 2013
Testing for drug hypersensitivity syndromesCraig M Rive, Jack Bourke, Elizabeth J Phillips
Australian and New Zealand Journal of Public Health|January 7, 2004
A cohort study of drink-driving motor vehicle crashes and alcohol-related diseasesMark Stevenson, Peter D'Alessandro, Jack Bourke, et al.
The Journal of Allergy and Clinical Immunology. Global|November 24, 2025
Cephalosporin allergy: R1 side-chain and penicillin cross-reactivity patterns in an Australian cohortBrittany Stevenson, Elizabeth Klinken, Michelle Trevenen, et al.
The Australasian Journal of Dermatology|December 17, 2025
Evidence for the Use of Janus Kinase (JAK) Inhibitors in the Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Scoping ReviewStephanie Tan, Jack Bourke, Rachael S Foster, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 21, 2022
Use of modern information communication technology to enable real-time consultation between primary and specialty care providersDominic Francis John Mallon, Justin Callaghan, Chloe Goodred, et al.
The Australasian Journal of Dermatology|July 29, 2022
Toxic epidermal necrolysis in adult patients: Experience from the West Australian CollaborationAaron J Frederiks, S Prasad Kumarasinghe, Fiona Wood, et al.
JAMA Internal Medicine|March 17, 2020
Development and Validation of a Penicillin Allergy Clinical Decision RuleJason A Trubiano, Sara Vogrin, Kyra Y L Chua, et al.
The Journal of Allergy and Clinical Immunology|February 19, 2019
HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptomsKatherine C Konvinse, Jason A Trubiano, Rebecca Pavlos, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
BMJ Case Reports|July 19, 2022
Transient cryoglobulinaemic vasculitis following ChAdOx1 nCoV-19 vaccineSadaf Ahmer, Jack Bourke, Nima Mesbah Ardakani
The Journal of Allergy and Clinical Immunology. in Practice|January 23, 2015
Improving the Effectiveness of Penicillin Allergy De-labelingJack Bourke, Rebecca Pavlos, Ian James, et al.
The Clinical Biochemist. Reviews|April 18, 2013
Testing for drug hypersensitivity syndromesCraig M Rive, Jack Bourke, Elizabeth J Phillips
Australian and New Zealand Journal of Public Health|January 7, 2004
A cohort study of drink-driving motor vehicle crashes and alcohol-related diseasesMark Stevenson, Peter D'Alessandro, Jack Bourke, et al.
The Journal of Allergy and Clinical Immunology. Global|November 24, 2025
Cephalosporin allergy: R1 side-chain and penicillin cross-reactivity patterns in an Australian cohortBrittany Stevenson, Elizabeth Klinken, Michelle Trevenen, et al.
The Australasian Journal of Dermatology|December 17, 2025
Evidence for the Use of Janus Kinase (JAK) Inhibitors in the Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Scoping ReviewStephanie Tan, Jack Bourke, Rachael S Foster, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 21, 2022
Use of modern information communication technology to enable real-time consultation between primary and specialty care providersDominic Francis John Mallon, Justin Callaghan, Chloe Goodred, et al.
The Australasian Journal of Dermatology|July 29, 2022
Toxic epidermal necrolysis in adult patients: Experience from the West Australian CollaborationAaron J Frederiks, S Prasad Kumarasinghe, Fiona Wood, et al.
JAMA Internal Medicine|March 17, 2020
Development and Validation of a Penicillin Allergy Clinical Decision RuleJason A Trubiano, Sara Vogrin, Kyra Y L Chua, et al.
The Journal of Allergy and Clinical Immunology|February 19, 2019
HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptomsKatherine C Konvinse, Jason A Trubiano, Rebecca Pavlos, et al.
Pageof 2